{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "SYNA",
  "name": "Synaptics Incorporated",
  "url": "https://orbyd.app/dossiers/SYNA/",
  "json_url": "https://orbyd.app/dossiers/SYNA.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "All-stock takeout capped the story and the acquirer de-rated: ON's ~19% announcement drop and slide to $87.37 cut the 1.350-ratio implied value from ~$160 to ~$118, with SYNA at $114.05. What's left is a 3.4% gross spread to a mid-2027 close, not a momentum leg. ON's 2026-08-03 print now sets the mark.",
  "invalidation_trigger": "A weekly close below $105 signals the arb spread widening past 10% versus the 1.350-ratio implied value — break risk being repriced rather than tracking the acquirer; secondary: an FTC/DOJ second request or China SAMR signal, or ON losing its post-deal lows.",
  "catalyst_date": "2026-08-03",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "m-and-a-special-situations",
    "semiconductors-analog",
    "ai-chips-memory"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Spread check 2026-07-17: SYNA $114.05 vs implied $117.95 (ON $87.37) = 3.4% gross to a mid-2027 close, ~3.7% annualized. Widening past 10% is the break-risk tell.",
    "Sell-side SYNA targets are just 1.35x their ON targets: Mizuho $170 (= ON $126), 13-analyst avg $145.33 (= ON ~$107.6) vs ON consensus $113.52, TD Cowen Hold $150. Do not read them as standalone conviction.",
    "Earnings blackout from ~2026-08-01: SYNA Q4 FY26 on 2026-08-06, but ON Q2 on 2026-08-03 is the larger mover for SYNA. No fresh entries into either.",
    "Prior $140 invalidation level was taken out in early July 2026 alongside ON's slide; the $133-142 pre-deal base and $138 20-day are dead references.",
    "Termination fees: $235M (Synaptics) / $320M reverse regulatory (onsemi). Main break risk is antitrust, incl. China SAMR on China-exposed revenue. S-4 not yet effective; shareholder vote estimated H1 2027.",
    "Onsemi divested two manufacturing facilities 2026-07-07 as part of cost reduction supporting the ~$200M annual synergy target.",
    "Standalone fundamentals underneath: Q3 FY26 (2026-05-07) rev $294.2M, EPS $1.09 vs $1.01 est, Core IoT +31% YoY, sixth straight double-digit growth quarter; but TTM rev $1.17B with a $48.1M net loss.",
    "Correlated duplicate of onsemi and the analog/power semi complex - adds no diversification to a book already carrying chip exposure."
  ],
  "body_markdown": "## Current Thesis\nThe edge-AI re-rating is over and the exit was a bad one. On 2026-06-25 onsemi agreed to buy Synaptics in an all-stock deal at a fixed 1.350 ON shares per SYNA share — roughly $160 implied at announcement, ~$7B, onsemi's largest acquisition. The market's verdict on the acquirer was brutal: ON fell about 19% that day, and it has kept sliding to $87.37 (2026-07-17). Because the exchange ratio is fixed and there is no cash component, SYNA holders are now simply long onsemi at 1.35x leverage minus a deal-risk discount. The arithmetic: 1.350 × $87.37 = $117.95 implied, against SYNA at $114.05 — a 3.4% gross spread to a close guided for mid-2027, or roughly 3.7% annualized. That is a fixed-income return with equity break risk attached, and it is the entire remaining opportunity set. SYNA is 23% below its $149.11 high and 12% below where it traded on announcement day, and none of that decline had anything to do with Synaptics' own business. The standalone narrative — Astra/Torq edge-AI silicon, the Google Coral tie-up shown at I/O on 2026-05-19, Core IoT +31% YoY — was sold to a strategic buyer for paper that then de-rated. Whoever buys SYNA here is expressing a view on onsemi, not on Synaptics.\n\n## Bull Case\n- Deal terms are firm and both boards approved unanimously (2026-06-25): 1.350 ON shares per SYNA, ~$7B enterprise value, ~19% premium to the 10-day VWAP of both stocks. Synaptics holders end up with roughly 12% of the combined company.\n- The spread is tight, which is the market saying break risk is low: $114.05 against $117.95 implied (2026-07-17) is a 3.4% discount for an ~11-month regulatory window. Arb desks are not pricing meaningful antitrust trouble.\n- Break protection is real on both sides: a $235M Synaptics termination fee and a $320M onsemi reverse regulatory termination fee. The reverse fee in particular signals onsemi's own confidence in clearance.\n- The operating business is not the problem. Q3 FY26 (reported 2026-05-07) delivered $294.2M revenue and $1.09 EPS against a $1.01 consensus — a sixth consecutive quarter of double-digit growth, with Core IoT +31% YoY.\n- Onsemi is actively cleaning up ahead of the close: on 2026-07-07 it agreed to divest two manufacturing facilities as part of its cost-reduction program, which supports the ~$200M annual synergy target and non-GAAP EPS accretion within 18 months of close.\n- Sell-side targets now function as ON targets in disguise. Mizuho raised SYNA to $170 with an Outperform in early July — that is 1.35 × a $126 ON target. The 13-analyst average of $145.33 implies ON near $107.6, close to ON's own $113.52 consensus. If ON mean-reverts toward consensus, SYNA carries mechanically.\n\n## Bear Case\n- All-stock with a fixed ratio means zero downside protection. ON has fallen from roughly $108 pre-announcement to $87.37, and the implied value of SYNA fell with it from ~$160 to ~$118 — a 26% destruction of the takeout price in three weeks, with no floor and no collar.\n- The acquirer's shareholders hated the deal. A 19% single-day drop on announcement is the market calling it dilutive or overpriced; CEO Hassane El-Khoury's response on CNBC was a long-term-strategic-value defence, which is what management says when the tape disagrees.\n- Upside is capped at 1.35 ON forever. There is no scenario in which Synaptics' own execution re-rates the stock — a blowout Q4 FY26 print changes nothing about what a holder receives.\n- The regulatory window is long: mid-2027 guided close, HSR plus foreign clearances including China SAMR on a business with meaningful China revenue, S-4 still to go effective, shareholder vote estimated H1 2027. Roughly a year of headline exposure with a ~3% carry to compensate.\n- Break math is ugly from here. A deal collapse likely lands SYNA back toward the pre-deal $133–142 consolidation only if the standalone story is intact; more realistically it re-prices against a de-rated semi tape, and the fundamentals underneath are a TTM $1.17B revenue business carrying a $48.1M net loss.\n- TD Cowen downgraded to Hold ($150 PT) and the 13-analyst consensus rating is Hold. The edge-AI upside thesis has no sell-side sponsor left that isn't just marking to the exchange ratio.\n\n## Setup & Price Structure\nThe chart is no longer Synaptics' chart. Since 2026-06-25 SYNA has traded as a near-perfect 1.35 beta to onsemi, and every technical level that mattered in the standalone era has been given up without a fight: the $140 pre-deal shelf broke in early July, the $133 early-June base went with it, and price closed at $114.05 on 2026-07-17 versus $122.84 on 2026-07-14 — a 7% drawdown in three sessions driven entirely by ON. RSI, moving averages, and volume profile carry no information here; the only two inputs are ON's price and the probability of clearance. The ceiling is mechanical at 1.350 × ON. The floor is wherever the arb spread stops being 3–4% and starts being 10%+, which is the market's way of saying it doubts the close. Post-announcement, $110 is the shelf that has held; below it the discount to implied value widens past the range typical for a clean, well-financed strategic deal. There is no momentum setup to trade — the price series has no independent variance left to exploit, and a fixed-ratio all-stock spread is the wrong instrument for a book that gets paid on trend persistence.\n\n## Catalyst Calendar (next 30 days)\n\n- **~August 2026, est.** — Form S-4 registration statement filing (proxy/prospectus). First real disclosure of background-of-the-merger, the banker fairness opinion, and any go-shop or interloper history. Watch for a low-ball fairness range as a tell on how contested the process was.\n- **~Q3 2026, est.** — HSR waiting period expiry or a second request. A second request pushes the timeline and widens the spread; a clean expiry compresses it toward parity.\n\n## Elapsed catalysts\n\n- **2026-08-03** — onsemi Q2 2026 earnings. This is now the dominant SYNA catalyst: a move in ON translates 1:1.35 into SYNA's mark, and with the acquirer already down ~19% post-deal, a weak guide compounds the exchange-ratio problem. *(passed 6d ago)*\n- **2026-08-06** — Synaptics Q4 FY26 (fiscal year-end) earnings. Largely academic given the pending deal; expect no meaningful standalone guide and no conference call substance beyond deal boilerplate. Treat 2026-08-01 onward as a blackout for fresh entries. *(passed 3d ago)*\n\n## What Would Change Our Mind\nThe read flips constructive if the arb spread compresses toward parity while ON itself stabilizes — Concretely: ON reclaiming the $100 handle with SYNA holding within 2% of 1.35× implied value would restore a directional reason to own it.\n\nThe read breaks if the spread blows out. A weekly close below $105 while ON holds current levels means the discount to implied value has widened past 10%, which is arb desks repricing break risk rather than tracking the acquirer. A second request from the FTC or DOJ, or any SAMR signal on the China-exposed revenue, does the same thing faster. A deal termination — either side paying the $235M/$320M fee — returns SYNA to a standalone story that no longer has sell-side sponsorship and a loss-making TTM P&L to defend.\n\nThe read stays what it is if nothing happens: a low-return, long-dated spread with a fat tail, which is not what a narrative-momentum book gets paid to hold.\n\n## Correlation Notes\nSYNA's residual variance against onsemi is now close to zero — owning it is owning ON with 1.35x notional and a termination-risk kicker. Any book already carrying analog/power semiconductor exposure gets a duplicated position, not a diversifying one. The name also sits inside the same chip cluster as the larger, more liquid AI-semi leaders, so it competes for the same risk budget while offering a fraction of the beta to the theme it was originally bought for. From a portfolio-construction view, the merger converted an idiosyncratic edge-AI expression into a rate-like carry trade stapled to a single mid-cap analog acquirer — a materially worse use of the same dollar.",
  "first_seen": "2026-05-08",
  "last_analyzed": "2026-07-19T11:45:34+00:00",
  "last_synthesized": "2026-07-19",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}